University Of Arizona
Clinical trials sponsored by University Of Arizona, explained in plain language.
-
Cancer drug fails to impress in early head and neck cancer trial
Disease control TerminatedThis study tested the drug abemaciclib given for 10-21 days before surgery in people with HPV-negative head and neck cancer. The goal was to see if it could shrink tumors and was safe. Only 7 people took part before the study was stopped early.
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Can a phone app ease pandemic stress for medical residents?
Symptom relief TerminatedThis study looked at whether using the Calm meditation app could help medical residents and fellows at a Phoenix hospital feel less stressed, anxious, and burned out during the COVID-19 pandemic. Only 7 people took part before the study was stopped early. Researchers measured str…
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated May 17, 2026 07:07 UTC
-
New weekly shot aims to slow Alzheimer's – early safety trial underway
Symptom relief TerminatedThis early study tested a weekly injection of allopregnanolone in 6 people with mild Alzheimer's or early memory loss. The main goal was to find a safe dose that works like the IV version. The study was stopped early, so results are limited.
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Sleep apnea treatment studied for IPF patients – but study stopped early
Knowledge-focused TerminatedThis study looked at whether CPAP, a machine that helps with breathing during sleep, could reduce acid reflux and lung inflammation in people with idiopathic pulmonary fibrosis (IPF) who also have sleep apnea. The goal was to measure changes in certain biomarkers linked to lung d…
Phase: NA • Sponsor: University of Arizona • Aim: Knowledge-focused
Last updated May 17, 2026 06:52 UTC